drugset / Trial / NCT02285283
Itraconazole for Fungal Sensitive Chronic Rhinosinusitis With Nasal Polyps
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this randomized controlled double-blinded trial is to determine if the addition of an oral antifungal to typical post-operative medical therapy can prevent or reduce the incidence of recurrence of nasal polyps in fungal sensitive patients with chronic rhinosinusitis with nasal polyps (CRSwNP).
Timeline
- Start
- 2014-11
- Primary completion
- 2019-05-15
- Completion
- 2019-05-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Itraconazole | Small molecule | 200 mg | Oral |